1. Home
  2. EVOK vs PRPO Comparison

EVOK vs PRPO Comparison

Compare EVOK & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • PRPO
  • Stock Information
  • Founded
  • EVOK 2007
  • PRPO N/A
  • Country
  • EVOK United States
  • PRPO United States
  • Employees
  • EVOK N/A
  • PRPO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • EVOK Health Care
  • PRPO Industrials
  • Exchange
  • EVOK Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • EVOK 7.1M
  • PRPO 9.9M
  • IPO Year
  • EVOK 2013
  • PRPO N/A
  • Fundamental
  • Price
  • EVOK $4.99
  • PRPO $7.47
  • Analyst Decision
  • EVOK
  • PRPO
  • Analyst Count
  • EVOK 0
  • PRPO 0
  • Target Price
  • EVOK N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • EVOK 9.5K
  • PRPO 5.5K
  • Earning Date
  • EVOK 03-13-2025
  • PRPO 03-28-2025
  • Dividend Yield
  • EVOK N/A
  • PRPO N/A
  • EPS Growth
  • EVOK N/A
  • PRPO N/A
  • EPS
  • EVOK N/A
  • PRPO N/A
  • Revenue
  • EVOK $8,617,036.00
  • PRPO $17,411,000.00
  • Revenue This Year
  • EVOK $97.35
  • PRPO $75.18
  • Revenue Next Year
  • EVOK $99.52
  • PRPO N/A
  • P/E Ratio
  • EVOK N/A
  • PRPO N/A
  • Revenue Growth
  • EVOK 100.35
  • PRPO 31.31
  • 52 Week Low
  • EVOK $3.54
  • PRPO $4.31
  • 52 Week High
  • EVOK $12.32
  • PRPO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 58.60
  • PRPO 69.56
  • Support Level
  • EVOK $4.68
  • PRPO $6.65
  • Resistance Level
  • EVOK $5.19
  • PRPO $6.90
  • Average True Range (ATR)
  • EVOK 0.31
  • PRPO 0.23
  • MACD
  • EVOK 0.03
  • PRPO 0.07
  • Stochastic Oscillator
  • EVOK 72.64
  • PRPO 94.61

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: